Results 161 to 170 of about 149,144 (263)

Conservative management of abdominal injuries. [PDF]

open access: yesUlus Cerrahi Derg, 2013
Okuş A   +5 more
europepmc   +1 more source

Penetrating injuries of the inferior vena cava [PDF]

open access: yes, 1963
BEHELER, EM   +3 more
core   +1 more source

Bioactives From Brown Algae: Antioxidant, Anti‐Inflammatory, Anticancer, and Antimicrobial Potential

open access: yesChemBioEng Reviews, EarlyView.
This review explores key bioactives in brown algae and their antioxidant, anti‐inflammatory, anticancer, and antimicrobial properties. Covering studies from 2014 to 2024, it highlights their relevance in pharmaceuticals, nutraceuticals, cosmetics, and foods, while addressing challenges and future directions to unlock their full potential.
Irvin Fonseca‐Barahona   +2 more
wiley   +1 more source

Abdominal injuries in university of port harcourt teaching hospital.

open access: yesNiger J Surg, 2015
Dodiyi-Manuel A, Jebbin NJ, Igwe PO.
europepmc   +1 more source

Hallmarks of Neuroblastoma—Pathophysiology, Diagnosis, and Therapeutic Interventions

open access: yesCancer Nexus, EarlyView.
ABSTRACT Neuroblastoma, the most common extracranial solid tumor in childhood, continues to challenge clinicians and researchers because of its heterogeneous nature and complex pathophysiology. Recent breakthroughs in molecular profiling revealed intricate genetic alterations driving tumor progression, necessitating an updated perspective on the ...
Abhimanyu Thakur, Anne Dijkstra
wiley   +1 more source

Safety and feasibility of open abdomen with negative pressure therapy in major liver trauma: a retrospective bicenter study. [PDF]

open access: yesLangenbecks Arch Surg
Coppola A   +6 more
europepmc   +1 more source

A Randomized Phase 1 Study Evaluating Pharmacokinetics, Safety, and Tolerability of a High‐Concentration, Long‐Acting Cabotegravir Formulation in Adults Without HIV

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Long‐acting (LA) cabotegravir 200‐mg/mL (CAB200) injections are approved for HIV‐1 prevention and as a complete LA HIV‐1 treatment regimen with rilpivirine. A high‐concentration suspension formulation, cabotegravir 400 mg/mL (CAB400‐D), was developed to enable less frequent dosing and self‐administration. This phase 1, double‐blind, randomized
Kelong Han   +16 more
wiley   +1 more source

Splenic injuries following upper endoscopic procedures: a systematic review of cases. [PDF]

open access: yesTransl Gastroenterol Hepatol
Behers BM   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy